{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:26:48Z","timestamp":1767148008273,"version":"build-2238731810"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8M0441"],"award-info":[{"award-number":["CMRPG8M0441"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jmii.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:50:10Z","timestamp":1680234610000},"page":"718-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of estimated glomerular filtration rate in HIV\/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study"],"prefix":"10.1016","volume":"56","author":[{"given":"Ching-Yen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Jhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-1561","authenticated-orcid":false,"given":"Chin-Shiang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Huang","family":"Liou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5925-2064","authenticated-orcid":false,"given":"Chia-Jui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1858-6367","authenticated-orcid":false,"given":"Sung-Hsi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6877-5345","authenticated-orcid":false,"given":"Kuan-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-2116","authenticated-orcid":false,"given":"Ning-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-0692","authenticated-orcid":false,"given":"Tun-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-5220","authenticated-orcid":false,"given":"Chen-Hsiang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2023.03.009_bib1","unstructured":"World Health Organization. WHO publishes updated guidance on hepatitis C infection. https:\/\/www.who.int\/news\/item\/24-06-2022-WHO-publishes-updated-guidance-on-hepatitis-C-infection. Accessed June 24, 2022."},{"key":"10.1016\/j.jmii.2023.03.009_bib2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2023.03.009_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac348","article-title":"Hepatitis C virus reinfection in people with HIV in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study","volume":"9","author":"Liu","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2023.03.009_bib4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/QAD.0b013e32833a0918","article-title":"Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, et\u00a0al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study","volume":"24","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2023.03.009_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmii.2023.03.009_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.02240218","article-title":"Clinical pharmacology in HIV therapy","volume":"14","author":"Atta","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jmii.2023.03.009_bib7","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1093\/cid\/ciu617","article-title":"Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"59","author":"Lucas","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2023.03.009_bib8","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus Tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2023.03.009_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40265-014-0247-z","article-title":"Sofosbuvir: a review of its use in patients with chronic hepatitis C","volume":"74","author":"Keating","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jmii.2023.03.009_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/17512433.2018.1451327","article-title":"Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors","volume":"11","author":"Dashti-Khavidaki","year":"2018","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.jmii.2023.03.009_bib11","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.14309\/crj.2017.84","article-title":"Acute interstitial nephritis associated with Sofosbuvir and Daclatasvir","volume":"4","author":"Ashraf","year":"2017","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jmii.2023.03.009_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/liv.13102","article-title":"Safety and efficacy of sofosbuvir-containing regimens in hepatitis C infected patients with impaired renal function","volume":"36","author":"Saxena","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jmii.2023.03.009_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/CN110276","article-title":"Acute interstitial nephritis following treatment with direct-acting antiviral agents in hepatitis C virus-infected patients: a case series","volume":"95","author":"Duque","year":"2021","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jmii.2023.03.009_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13018","article-title":"Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients","volume":"21","author":"Huang","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jmii.2023.03.009_bib15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3748\/wjg.v28.i11.1172","article-title":"Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections","volume":"28","author":"Sun","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2023.03.009_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40121-021-00424-8","article-title":"Real-world experience with coformulated Ledipasvir and Sofosbuvir for HIV-positive patients with HCV genotype 2 infection: a multicenter, retrospective study","volume":"10","author":"Liou","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jmii.2023.03.009_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1089\/aid.2017.0271","article-title":"Incidence of acute kidney injury in patients coinfected with HIV and hepatitis C virus receiving tenofovir disoproxil fumarate and ledipasvir\/sofosbuvir in a real-world, urban, Ryan White Clinic","volume":"34","author":"Michal","year":"2018","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.jmii.2023.03.009_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/jvh.13502","article-title":"Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy","volume":"28","author":"Liu","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jmii.2023.03.009_bib19","unstructured":"The American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA). HCV guidance: recommendations for testing, managing, and treating hepatitis C. http:\/\/www.HCVguidance.org. Accessed August, 2020."},{"key":"10.1016\/j.jmii.2023.03.009_bib20","unstructured":"Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. https:\/\/aidsinfo.nih.gov\/guidelines\/html\/1\/adult-and-adolescent-arv\/0. Accessed June 13, 2019."},{"key":"10.1016\/j.jmii.2023.03.009_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmii.2023.03.009_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a kidney disease: improving global outcomes (KDIGO) consensus conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Ins"},{"key":"10.1016\/j.jmii.2023.03.009_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2019.11.014","article-title":"Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals","volume":"72","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2023.03.009_bib24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cgh.2021.07.037","article-title":"Impact of sofosbuvir-based direct-acting antivirals on renal function in chronic hepatitis C patients with impaired renal function: a large cohort study from the nationwide HCV registry program (TACR)","volume":"20","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jmii.2023.03.009_bib25","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/jvh.13193","article-title":"Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: a real-world experience","volume":"26","author":"Tsai","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jmii.2023.03.009_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12985-019-1140-x","article-title":"Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4\u20135 chronic kidney disease: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2019","journal-title":"Virol J"},{"key":"10.1016\/j.jmii.2023.03.009_bib27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit043","article-title":"Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study","volume":"207","author":"Ryom","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2023.03.009_bib28","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/QAD.0000000000002223","article-title":"Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials","volume":"33","author":"Gupta","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2023.03.009_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008046","article-title":"Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: a case report","volume":"96","author":"Novick","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jmii.2023.03.009_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S2055-6640(20)30248-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?","volume":"4","author":"Hill","year":"2018","journal-title":"J Virus Erad"},{"issue":"S1","key":"10.1016\/j.jmii.2023.03.009_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/liv.13022","article-title":"HCV and the kidney","volume":"36","author":"Corouge","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jmii.2023.03.009_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5414\/CNP69298","article-title":"Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature","volume":"69","author":"Ahmed","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jmii.2023.03.009_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/hiv.12249","article-title":"Monitoring of kidney function in HIV-positive patients","volume":"16","author":"Yombi","year":"2015","journal-title":"HIV Med"},{"key":"10.1016\/j.jmii.2023.03.009_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003674","article-title":"Incidence, outcomes, and risk factors of community-acquired and hospital-acquired acute kidney injury: a retrospective cohort study","volume":"95","author":"Hsu","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jmii.2023.03.009_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ckj\/sfx090","article-title":"Intravenous drug users who require dialysis: causes of renal failure and outcomes","volume":"11","author":"Scott","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jmii.2023.03.009_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.5301\/IJAO.2011.8509","article-title":"Acute kidney injury due to rhabdomyolysis in narcotic drug users","volume":"34","author":"Kosmadakis","year":"2011","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jmii.2023.03.009_bib37","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function-measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2023.03.009_bib38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jcph.1132","article-title":"Cystatin C is a more reliable biomarker for determining eGFR to support drug development studies","volume":"58","author":"Kar","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jmii.2023.03.009_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review","volume":"313","author":"Levey","year":"2015","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1016\/j.jmii.2023.10.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000}}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T13:36:37Z","timestamp":1708004197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118223000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1684118223000774"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2023.03.009","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of estimated glomerular filtration rate in HIV\/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}